NEW YORK (GenomeWeb News) – Poland's University of Lodz will use Cellectricon's cell-based screening system in its genomic research programs, the company said today.

Under the agreement, the university will use the Cellaxess HT system for high-throughput transfection, which the company said enables the delivery of any genetic material to cells without the use of reagents.

The university bought the Cellaxess system with funding from Poland's Innovative Economy Operational Program, which is supported in part by the EU's European Regional Development Fund.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.